Excerpt from Teratology and Drug Use During PregnancySynonyms, Key Words, and Related Terms: teratogenic, teratogenicity, human X-linked dominant chondrodysplasia punctata, Happle syndrome, Happle's syndrome, Conradi-Hunermann-Happle syndrome, CDPX2, emopamil-binding protein, EBP, fetal ototoxicity, intrauterine growth retardation, IUGR, intrauterine growth restriction, fetal growth restriction, birth defects, pregnancy complications, Dilantin congenital defects, phenytoin toxicity, fetal phenytoin syndrome, fetal hydantoin syndrome, FHS, meadow syndrome, congenital hydantoin syndrome, Dilantin syndrome, fetal Dilantin syndrome, hydantoin syndrome, fetal trimethadione syndrome, fetal warfarin syndrome, warfarin toxicity seizure disorders in pregnancy, FDA pregnancy category, pregnancy category D, pregnancy category X, drug use during pregnancy and lactation, drug adverse effects, drug exposure during pregnancy, psychosocial and environmental pregnancy risks Please click here to view the full topic text: Teratology and Drug Use During PregnancyDrug use is an uncommon cause of birth defects, yet approximately 200,000 children (3-5% of live births) are born with birth defects each year.1 While some papers estimate that 1-3% of birth defects are thought to be caused by medications taken during pregnancy, the authors could not find a source for this statement that was based on study data. Please click here to view the full topic text: Teratology and Drug Use During Pregnancy |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |